NeuroMetrix Corp (NURO): Utang-utang marang kapitalisasi buku

Tandha merek NeuroMetrix Inc (NURO)

NeuroMetrix, Inc. (NURO) is currently focusing on updating the software for its Quell neurostimulator and sensors. The debt concentration level within the balance sheet capitalization clearly demonstrates the financial dynamics, with the latest figure standing at 0.01. Business development relies on the robotization of SMT lines to eliminate manual labor. Simultaneously, the company is implementing energy-efficient solutions and biodegradable packaging to comply with ESG standards.

NURO (NeuroMetrix Corporation) riwayat Utang marang nilai buku saka 04.07.2022 nganti 11.05.2025

Ringkesan rincian data analitis NeuroMetrix Inc (NURO)

- rega lan prakiraan konsensus rega:
Rega saham NeuroMetrix, Inc.|NURO - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Kapitalisasi pasar NeuroMetrix Corporation|NURO - Rega Tumbas Perusahaan
- data kapitalisasi buku:
Nilai Buku saben Saham NeuroMetrix|NURO - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku neurometrix.com|NURO - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas NeuroMetrix, Inc.|NURO - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas NeuroMetrix Corp|NURO - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku NeuroMetrix Corporation
Analisis fundamental perusahaan:NeuroMetrix, Inc.
Produk asli NeuroMetrix Corporation

The ratio is calculated as the sum of all liabilities divided by the company's equity. This metric determines the business's dependence on borrowed funds and its level of financial autonomy. For NeuroMetrix, Inc. (NURO), the leverage balance is critical when scaling sales of Quell neurostimulators and diagnostic equipment. Reducing the debt load enhances investment security. The trend of financial debt relative to book capitalization clearly demonstrates the company's stability.

Karo sapa NeuroMetrix, Inc. saingan

ISRG - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku danaher.com DHR|Utang-utang marang kapitalisasi buku BDX (Becton Dickinson)|STE - Utang-utang marang aset resik|WST (West Pharmaceutical Services Inc) - Utang-utang marang kapitalisasi buku|Baxter Healthcare (BAX) - Utang marang nilai buku|MASI (Masimo Corporation) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku STVN|Rasio utang marang kapitalisasi buku Teleflex (TFX)|Rasio utang marang kapitalisasi buku Merit Medical Systems, Inc. MMSI|Utang marang nilai buku Envista Holdings Corp|Rasio utang marang aset resik ICU Medical Inc. ICUI|Utang-utang marang kapitalisasi buku XRAY (DENTSPLY SIRONA Inc.)|LMAT: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku AtriCure|STAA (STAAR Surgical Co.) - Rasio utang marang nilai buku|NAGE: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik ZimVie Corp (ZIMV)|Utang marang nilai buku AngioDynamics, Inc.|Utang marang modal buku CERS (cerus.com)|Rasio utang marang kapitalisasi buku Teknova|MGRM - Rasio utang marang aset resik|Sharps Tech - Utang marang nilai buku|INFU: Utang-utang marang kapitalisasi buku|UTMD (Utah Medical Products) - Rasio utang marang kapitalisasi buku|KORU Medical (KRMD) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku NYXH (Nyxoah)|Utang-utang marang nilai buku MBOT|Rasio utang marang kapitalisasi buku Pro-Dex Corp PDEX|Rasio utang marang nilai buku Zentek Corp ZTEK|Utang marang nilai buku Elutia Inc. (ELUT)|milestonescientific.com - Utang marang modal buku|Rasio utang marang kapitalisasi buku NXGL (NEXGEL)|RVP: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Harvard Bioscience, Inc.|Femasys Corporation (FEMY) - Rasio utang marang nilai buku|Utang-utang marang kapitalisasi buku MHUA (Meihua Medical Technologies)|Utang-utang marang nilai buku Predictive Oncology Corp (POAI)|Utang marang nilai buku CJMB|Utang-utang marang kapitalisasi buku ATRI (Atrion Corp.)